Meeting
2016 ASCO Annual Meeting
Improved survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: results of the German Network Genomic Medicine.
Authors
Anna Kostenko
Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany
Anna Kostenko , Sebastian Yves Friedrich Michels , Jana Fassunke , Matthias Scheffler , Sabine Merkelbach-Bruse , Rieke Nila Fischer , Merle Gerigk , Juliane Sueptitz , Florian Kron , Jan Peter Glossmann , Reinhard Buettner , Juergen Wolf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9085)
DOI
10.1200/JCO.2016.34.15_suppl.9085
Abstract #
9085
Poster Bd #
408
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).
First Author: Shingo Matsumoto
Poster
2022 ASCO Annual Meeting
Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology.
First Author: Kubra Karagoz
Poster
2019 ASCO Annual Meeting
Genomic characterization of lung tumors and metastatic (Met) sites in advanced (Adv) NSCLC.
First Author: Melinda D Willard
Poster
2018 ASCO Annual Meeting
Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.
First Author: Nathan A. Pennell